Cureatr to leverage PAST’s robust PDMP interface and analytics in Meds
360° Medication Management Solution to help clinicians in the fight
against opioid and substance abuse.
ORLANDO, Fla.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/healthIT?src=hash” target=”_blank”gt;#healthITlt;/agt;–Today at HIMSS19,
announced a major enhancement to their recently released medication
management solution, Meds
360°, by adding vital national prescription drug monitoring program
(PDMP) data to combat the opioid epidemic via a partnership with PAST.
PDMPs are state-level databases that track controlled substance
prescriptions, providing health authorities timely information about
prescribing and patient behavior that contribute to addiction and abuse.
According to the Centers
for Disease Control and Prevention, “evaluations of PDMPs have
illustrated changes in prescribing behaviors, use of multiple providers
by patients, and decreased substance abuse treatment admissions.”
Legislation authorizing the creation and operation of a PDMP has been
passed in 49 states, the District of Columbia, and Guam. In all but six
states, DC, and Puerto Rico, it is mandatory for either the prescriber,
the dispenser, or both to check the state-wide PDMP database when new
prescriptions of Schedule II-IV drugs are written.
Cureatr solves this problem by integrating PAST’s PDMP data and
analytics from up to 41 states into Meds 360°. The PDMP lookup will be
accessible with a single click presented using Cureatr’s novel
timeline-based interface, highlighting therapeutic duplications,
strength changes, prescribers, and fill dates. Additionally, alerting is
available for multi-prescriber/multi-pharmacy and MMEs in excess of
“PAST has long been dedicated to fighting the substance use disorder
epidemic with innovative solutions to increase the effectiveness and
value of PDMP reports,” said Rick Bunker, CEO, at PAST. “Partnering with
Cureatr was a no-brainer. Their Meds 360° platform already provides a
wealth of real-time medication data to empower care decisions and
address many issues with suboptimal medication management. We see our
PDMP data and analytics as another piece in the puzzle to help
clinicians give their patients the best possible care.”
“We are thrilled to be working with PAST as they’ve built a unique data
and analytics platform that just doesn’t exist elsewhere,” said Richard
Resnick, CEO of Cureatr. “Despite the benefits of PDMP checks and the
mandates to perform them, the national average for PDMP checks by
controlled substance prescribers is merely eight patients per 35. Simply
by using Meds 360° with the PAST PDMP data and analytics, clinicians and
administrators will gain nearly 100% compliance with their state-based
Cureatr is the country’s leading mobile, healthcare information
provider, connecting patient data that exists outside of the electronic
medical record to create a picture of a whole patient, giving clinicians
vital depth and context into who they are, what illnesses they’ve faced,
what medications they’ve taken, where they’ve been within healthcare
facilities and where they’re going, as they’re going there, in
real-time, so clinicians can take real action to deliver better care.
For additional information, please visit cureatr.com.
PAST helps health care professionals fight the growing substance use
disorder epidemic; the leading cause of death in the US for people under
50. PAST makes PDMP checks easier, faster, clearer, and more meaningful.
PAST users achieve compliance with less effort and see vital medical
information on their patients’ controlled substance prescription
presented in clearer, more useful way.